Christopher K. West
Career history of Christopher K. West
Former positions of Christopher K. West
Companies | Position | Start | End |
---|---|---|---|
Warner Chilcott Ltd.
Warner Chilcott Ltd. Pharmaceuticals: MajorHealth Technology Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda. | Sales & Marketing | - | - |
CUTERA, INC. | Sales & Marketing | 2009-08-03 | - |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Sales & Marketing | 2008-01-06 | - |
Training of Christopher K. West
US Military Academy | Undergraduate Degree |
Duke University | Masters Business Admin |
Statistics
International
United States | 5 |
Bermuda | 2 |
Operational
Sales & Marketing | 3 |
Undergraduate Degree | 2 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CUTERA, INC. | Health Technology |
Private companies | 2 |
---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Warner Chilcott Ltd.
Warner Chilcott Ltd. Pharmaceuticals: MajorHealth Technology Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda. | Health Technology |
- Stock Market
- Insiders
- Christopher K. West
- Experience